Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05832567 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mechanisms of Open and Hidden Placebo in Stroke Recovery

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Jun 30, 2026 to Dec 30, 2026v5
  2. Primary completion date: Jun 1, 2025 to Jun 1, 2026
    • Study completion date: Jun 30, 2025 to Jun 30, 2026
    v4
  3. Start date: Nov 1, 2023 to Sep 11, 2023v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2023 to Nov 1, 2023
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial aims to investigate whether placebo in isolation (open and hidden) has a specific neural signature in stroke subjects thus providing a novel mechanism to explain placebo effects that can be used to ultimately enhance stroke rehabilitation therapies.
Trial Details
NCT Number NCT05832567
Lead Sponsor Spaulding Rehabilitation Hospital
Conditions
(from sponsor)		 Stroke, Hemiparesis
Related terms Paresis, Stroke
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov